Galmed Pharmaceuticals (NASDAQ:GLMD) Shares Cross Below 200-Day Moving Average – Should You Sell?

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)’s share price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $3.97 and traded as low as $2.73. Galmed Pharmaceuticals shares last traded at $2.97, with a volume of 31,645 shares traded.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Galmed Pharmaceuticals in a research report on Wednesday, October 9th. They issued a “sell” rating for the company.

Galmed Pharmaceuticals Price Performance

The business has a fifty day moving average of $3.32 and a 200 day moving average of $3.96. The stock has a market cap of $1.90 million, a PE ratio of -0.18 and a beta of 0.75.

About Galmed Pharmaceuticals

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus.